title: Bacteremia caused by Arcobacter butzleri in an immunocompromised host.
abstract: Arcobacter butzleri is an emerging pathogen that has been implicated as the causative agent of persistent watery diarrhea. We describe a case involving a patient with chronic lymphocytic leukemia who developed invasive A. butzleri bacteremia. This case illustrates the unique challenges involved in diagnosing infections caused by emerging gastrointestinal pathogens.
authors: Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
authors: Esther
authors: E
authors: Arguello
authors: Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
authors: Caitlin C
authors: CC
authors: Otto
authors: Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
authors: Peter
authors: P
authors: Mead
authors: Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA BabadyN@mskcc.org.
authors: N Esther
authors: http://orcid.org/0000-0003-4399-1249
authors: NE
authors: Babady
mesh_terms: D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D020640:Arcobacter / Q000302:isolation & purification*; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D016867:Immunocompromised Host; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008297:Male; D011687:Purines / Q000009:adverse effects / Q000627:therapeutic use; D052999:Quinazolinones / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D011687:Purines; D052999:Quinazolinones; C552946:idelalisib